M4 Brain aging (normal vs. pathological)

Topic

During physiological brain aging, brain tissue undergoes a slow, gradual decline in three distinct properties: synaptic density, myelin integrity, and cerebrovascular reserve—that is, the tissue's capacity to increase incoming blood flow in response to heightened metabolic demand. This decline is further accompanied by a progressive accumulation of mitochondrial oxidative damage within the brain tissue, increasingly compromising its energy metabolism.

The cognitive impact of this brain tissue decline follows the same functional pattern used to describe cognitive deterioration in Alzheimer's disease, yet it is moderated by cognitive reserve, which acts as a functional buffer: the greater the cognitive reserve a person has built over a lifetime through intellectual and social activity, the lesser the cognitive impact resulting from a given degree of brain tissue decline.

The model explicitly distinguishes normal aging from pathological aging using a combined threshold involving both accumulated damage and synaptic loss in the brain tissue. As long as accumulated damage and synaptic loss remain below this combined threshold, the deterioration remains consistent with healthy aging; however, beyond this threshold, brain tissue deterioration is no longer compatible with healthy aging and approaches the phenotype associated with other conditions in this catalog, such as Alzheimer's disease. Ultimately, it is this brain tissue—with its gradual decline in synaptic density, myelin integrity, cerebrovascular reserve, and mitochondrial oxidative damage, all moderated by an individual's cognitive reserve—that determines whether aging remains healthy or crosses the combined threshold into pathological aging.

ID:4276